Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT05768776

Outpatient Holmium LASER Enucleation of the Prostate: Benefit of MOSES(TM) 2.0 Technology

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

The aim of this study is to compare the success rate of outpatient surgery after holmium LASER enucleation of the prostate (HoLEP) for the treatment of BPH with and without the use of the MOSES 2.0 effect.

Official title: To Compare the Effectiveness of the MOSES 2.0 Technology to the Non-MOSES Technology on the Success Rate of Holmium LASER Enucleation of the Prostate (HoLEP) Performed on an Outpatient Basis in the Context of Benign Prostatic Hypertrophy.

Key Details

Gender

MALE

Age Range

50 Years - Any

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2023-06-28

Completion Date

2025-07

Last Updated

2025-06-25

Healthy Volunteers

No

Interventions

PROCEDURE

HoLEP patients without MOSES(TM) 2.0 effect (open label)

HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, without using MOSES technology

PROCEDURE

HoLEP patients with MOSES(TM) 2.0 effect (open label)

HoLEP surgery for the treatment of Benign Prostate Hyperthrophy, with the use of MOSES technology

Locations (1)

CHU de Bordeaux

Bordeaux, France